Use of preneoplastic lesions in colon and liver in experimental oncology

Authors

  • Veronika A. Ehrlich
  • Wolfgang Huber
  • Bettina Grasl-Kraupp
  • Armen Nersesyan
  • Siegfried Knasmueller

Abstract

The present article gives a brief overview on the use of altered hepatic foci (AHF) and aberrant crypt foci (ACF) in the colon in experimental cancer research. These foci are easily detectable preneoplastic lesions, which have been discovered approximately 30 years ago. AHF and ACF are valuable tools for the detection of cancer - initiating and promoting compounds, and for the detection of chemoprotective agents. They were also successfully used in numerous studies aimed at elucidating the molecular mechanisms of early neoplasia, such as alterations of the expressions of oncogene and tumor suppressor genes, and changes in the activities of cancer associated enzymes.

Author Biographies

Veronika A. Ehrlich

Wolfgang Huber

Bettina Grasl-Kraupp

Armen Nersesyan

Siegfried Knasmueller

Downloads

Published

2004-09-01

How to Cite

Ehrlich, V. A., Huber, W., Grasl-Kraupp, B., Nersesyan, A., & Knasmueller, S. (2004). Use of preneoplastic lesions in colon and liver in experimental oncology. Radiology and Oncology, 38(3). Retrieved from https://www.radioloncol.com/index.php/ro/article/view/1332

Issue

Vol. 38 No. 3 (2004)

Section

Experimental oncology

License

License to Publish

Please read the terms of this agreement, print, initial page 1, sign page 3, scan and send the document as one file attached to an e-mail to gsersa@onko-i.si

Copyright - PDF